Macquarie Group
CBIO

Macquarie Group’s Crescent Biopharma CBIO Stock Holding History

Macquarie Group’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19
Closed -$6 – 1993
2024
Q1 		$6 Buy
+19
New +$5.67K ﹤0.01% 1767
2019
Q1 		– Sell
-4
Closed -$4K – 1804
2018
Q4 		$4K Hold
4
– – ﹤0.01% 2130
2018
Q3 		$6K Sell
4
-44
-92% -$66.5K ﹤0.01% 2048
2018
Q2 		$77K Sell
48
-709
-94% -$1.22M ﹤0.01% 1892
2018
Q1 		$1.23M Buy
+757
New +$1.57M ﹤0.01% 1119

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return